A modified clot-based assay to measure negatively charged procoagulant phospholipids
Abstract Growing evidence supports a role for extracellular vesicles (EVs) in haemostasis and thrombosis due to exposure of negatively charged procoagulant phospholipids (PPL). Current commercial PPL-dependent clotting assays use chemically phospholipid depleted plasma to measure PPL activity. The p...
Guardado en:
Autores principales: | Cathrine Ramberg, S. Jamaly, N. Latysheva, L. Wilsgård, T. Sovershaev, O. Snir, J.-B. Hansen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e92f3e3a24046bab373fe1dea36872c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Rita Orbán-Kálmándi, et al.
Publicado: (2021) -
Limitations of using synthetic blood clots for measuring in vitro clot capture efficiency of inferior vena cava filters
por: Robinson RA, et al.
Publicado: (2013) -
Elevated levels of procoagulant plasma microvesicles in dialysis patients.
por: James O Burton, et al.
Publicado: (2013) -
Increased activity of procoagulant factors in patients with small cell lung cancer.
por: Shona Pedersen, et al.
Publicado: (2021) -
Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes
por: Zhang C, et al.
Publicado: (2020)